Evaluation of a Pharmacist-managed Diabetes Medication Therapy Adherence Clinic

Overview

Journal Pharm Pract (Granada)

Date 2014 Aug 16

PMID 25126149

Citations 19

Authors

Phei Ching Lim

Kelvin Lim

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Patient adherence to prescribed medication regimens is important in diabetes care to prevent or delay microvascular and macrovascular complications such as retinopathy, nephropathy and myocardial infarction. In Penang Hospital, Malaysia, pharmacists collaborate with physicians in diabetes care through a pharmacist-managed Diabetes Medication Therapy Adherence Clinic (DMTAC) in the Endocrine Clinic, in operation since 2006.

Objective: To evaluate the effectiveness of the pharmacist-managed DMTAC program in improving glycaemic control, lipid parameters and patients' medication adherence.

Method: A retrospective study among patients enrolled in the DMTAC program was conducted between September 2007 and December 2008. Data was included from patients with a glycosylated haemoglobin (HbA1c) >8% and who had completed eight visits with the pharmacists. Medical records and DMTAC forms that provided patients' demographics, medication regimens, adherence and laboratory parameters as well as pharmacists' interventions were reviewed. HbA1c, fasting blood glucose (FBG), low-density lipoprotein cholesterol (LDL), triglycerides (TG) and high-density lipoprotein cholesterol (HDL) were evaluated. Documented data of patients' adherence to medication regimen [Modified Morisky Medication Adherence Score (MMMAS); high adherence if score >8, medium adherence if score 6 to <8 and low adherence if score <6] was also evaluated.

Results: A total of 43 patients (53.5% females; 46.5% Malays, 44.2% Chinese and 9.3% Indians) were included in the analysis. A mean reduction in HbA1c of 1.73% (p<0.001), mean reduction in FBG of 2.65mmol/l (p=0.01) and mean reduction in LDL cholesterol of 0.38mmol/l (p=0.007) were achieved. The difference in TG and HDL cholesterol were not significant. Patients' adherence to medication regimens improved significantly with an increase in the mean MMMAS score from 7.00 to 10.84 (p<0.001) after completion of the DMTAC program.

Conclusion: The pharmacist-managed DMTAC program resulted in significant improvements in HbA1c, glucose and LDL cholesterol levels as well as medication adherence in patients with diabetes.

Citing Articles

Narrative review of comprehensive management strategies for diabetic retinopathy: interdisciplinary approaches and future perspectives.

Pei X, Li Z BMJ Public Health. 2025; 3(1):e001353.

PMID: 40017934 PMC: 11812885. DOI: 10.1136/bmjph-2024-001353.

A digital health-supported and community pharmacy-based lifestyle intervention program for adults with pre-diabetes: a study protocol for a cluster randomised controlled trial.

Teoh K, Ng C, Chong C, Cheong W, Ng Y, Bell J BMJ Open. 2024; 14(10):e083921.

PMID: 39448216 PMC: 11579589. DOI: 10.1136/bmjopen-2024-083921.

Impact of Attendance to a Pharmacist-Managed Medication Adherence Clinic on Glycemic Control and Risk Factors for Non-Completion Among Persons with Type 2 Diabetes Mellitus in Selangor, Malaysia.

Hassan F, Hatah E, Chong W, Mhd Ali A Ther Clin Risk Manag. 2024; 20:495-503.

PMID: 39156759 PMC: 11328843. DOI: 10.2147/TCRM.S442026.

The influence of pharmacist-led collaborative care on clinical outcomes in type 2 diabetes mellitus: a multicenter randomized control trial.

Iqbal M, Alqahtani S, Mubarak N, Shahid S, Mohammed R, Mustafa A Front Public Health. 2024; 12:1323102.

PMID: 38476498 PMC: 10929610. DOI: 10.3389/fpubh.2024.1323102.

The impact of pharmacist interventions, follow-up frequency and default on glycemic control in Diabetes Medication Therapy Adherence Clinic program: a multicenter study in Malaysia.

Lim P, Tan H, Mohd Noor N, Chang C, Wong T, Tan E J Pharm Policy Pract. 2023; 16(1):83.

PMID: 37408067 PMC: 10320936. DOI: 10.1186/s40545-023-00583-8.

References

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Kroner B, Kelley C, Trilli L . Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998; 32(6):636-41. DOI: 10.1345/aph.17095. View

Goudswaard A, Stolk R, Zuithoff N, de Valk H, Rutten G . Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care. Diabet Med. 2004; 21(5):491-6. DOI: 10.1111/j.1464-5491.2004.01153.x. View

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y . Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006; 31(5):409-19. DOI: 10.1111/j.1365-2710.2006.00759.x. View

Leal S, Glover J, Herrier R, Felix A . Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004; 27(12):2983-4. DOI: 10.2337/diacare.27.12.2983. View

Cramer J . A systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27(5):1218-24. DOI: 10.2337/diacare.27.5.1218. View

Morisky D, Ang A, Krousel-Wood M, Ward H . Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348-54. PMC: 2562622. DOI: 10.1111/j.1751-7176.2008.07572.x. View

Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258):405-12. PMC: 27454. DOI: 10.1136/bmj.321.7258.405. View

10.

. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2001; 894:i-xii, 1-253. View

11.

Downs J, Clearfield M, Weis S, Whitney E, Shapiro D, Beere P . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998; 279(20):1615-22. DOI: 10.1001/jama.279.20.1615. View

12.

Schillinger D, Grumbach K, Piette J, Wang F, Osmond D, Daher C . Association of health literacy with diabetes outcomes. JAMA. 2002; 288(4):475-82. DOI: 10.1001/jama.288.4.475. View

13.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

14.

Kiel P, McCord A . Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005; 39(11):1828-32. DOI: 10.1345/aph.1G356. View

15.

Mafauzy M . Diabetes mellitus in Malaysia. Med J Malaysia. 2007; 61(4):397-8. View

16.

Renders C, Valk G, Griffin S, Wagner E, Eijk Van J, Assendelft W . Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001; 24(10):1821-33. DOI: 10.2337/diacare.24.10.1821. View

17.

Anaya J, Rivera J, Lawson K, Garcia J, Luna Jr J, Ortiz M . Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008; 65(19):1841-5. DOI: 10.2146/ajhp070568. View

18.

. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344(8934):1383-9. View

19.

Sever P, Dahlof B, Poulter N, Wedel H, Beevers G, Caulfield M . Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre.... Lancet. 2003; 361(9364):1149-58. DOI: 10.1016/S0140-6736(03)12948-0. View

20.

Odegard P, Goo A, Hummel J, Williams K, Gray S . Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005; 39(3):433-40. DOI: 10.1345/aph.1E438. View